Related Experiment Video
Updated: Feb 13, 2026
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Inflammasome Activation by Methamphetamine Potentiates Lipopolysaccharide Stimulation of IL-1β Production in
Enquan Xu1, Jianuo Liu1, Han Liu1
1Neurophysiology Laboratory, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5880, USA.
Abstract:
Methamphetamine (Meth) is an addictive psychostimulant abused worldwide. Ample evidence indicate that chronic abuse of Meth induces neurotoxicity via microglia-associated neuroinflammation and the activated microglia present in both Meth-administered animals and human abusers. The development of anti-neuroinflammation as a therapeutic strategy against Meth dependence promotes research to identify inflammatory pathways that are specifically tied to Meth-induced neurotoxicity. Currently, the exact mechanisms for Meth-induced microglia activation are largely unknown. NLRP3 is a well-studied cytosolic pattern recognition receptor (PRR), which promotes the assembly of the inflammasome in response to the danger-associated molecular patterns (DAMPs). It is our hypothesis that Meth activates NLRP3 inflammasome in microglia and promotes the processing and release of interleukin (IL)-1β, resulting in neurotoxic activity. To test this hypothesis, we studied the effects of Meth on IL-1β maturation and release from rat cortical microglial cultures. Incubation of microglia with physiologically relevant concentrations of Meth after lipopolysaccharide (LPS) priming produced an enhancement on IL-1β maturation and release. Meth treatment potentiated aggregation of inflammasome adaptor apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), induced activation of the IL-1β converting enzyme caspase-1 and produced lysosomal and mitochondrial impairment. Blockade of capase-1 activity, lysosomal cathepsin B activity or mitochondrial ROS production by their specific inhibitors reversed the effects of Meth, demonstrating an involvement of inflammasome in Meth-induced microglia activation. Taken together, our results suggest that Meth triggers microglial inflammasome activation in a manner dependent on both mitochondrial and lysosomal danger-signaling pathways.
Insights
Methamphetamine abuse causes neuroinflammation by activating microglia. This study reveals Meth triggers the NLRP3 inflammasome pathway, leading to neurotoxic interleukin-1β release, offering therapeutic targets for addiction.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Chronic methamphetamine (Meth) abuse is linked to neurotoxicity through microglia-associated neuroinflammation.
- Understanding Meth-induced microglia activation mechanisms is crucial for developing anti-neuroinflammation therapies for Meth dependence.
Purpose of the Study:
- To investigate the hypothesis that Meth activates the NLRP3 inflammasome in microglia, promoting interleukin-1β (IL-1β) processing and release, thereby causing neurotoxicity.
- To elucidate the specific pathways involved in Meth-induced microglia activation.
Main Methods:
- Rat cortical microglial cultures were treated with Meth after lipopolysaccharide (LPS) priming.
- Assessed IL-1β maturation and release, inflammasome adaptor ASC aggregation, caspase-1 activation, and lysosomal/mitochondrial function.
- Utilized specific inhibitors for caspase-1, cathepsin B, and mitochondrial reactive oxygen species (ROS).
Main Results:
- Meth treatment enhanced IL-1β maturation and release from microglia.
- Meth induced inflammasome adaptor ASC aggregation and caspase-1 activation.
- Lysosomal and mitochondrial impairment, including ROS production, were observed following Meth treatment.
- Inhibiting caspase-1, cathepsin B, or mitochondrial ROS reversed Meth-induced effects.
Conclusions:
- Methamphetamine triggers microglial inflammasome activation, specifically involving the NLRP3 pathway.
- Mitochondrial and lysosomal danger-signaling pathways are critical mediators of Meth-induced microglia activation.
- These findings highlight the inflammasome pathway as a potential therapeutic target for Methamphetamine dependence and associated neurotoxicity.
More Related Videos
Related Concept Videos
01:28Action Potential: Phases of Stimulation
Resting Phase:
In this phase, the cell's membrane is at its resting potential, typically around -70 millivolts (mV) for neurons. Inside the cell, there is a higher concentration of potassium ions (K+) and a lower concentration of sodium ions (Na+). Voltage-gated sodium channels are closed, and...
01:10Thermodynamics: Chemical Potential and Activity
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
01:19Formation of Lipopolysaccharides
01:21The Resting Membrane Potential
02:58Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
03:02Standard Electrode Potentials